0001104659-24-009452.txt : 20240201 0001104659-24-009452.hdr.sgml : 20240201 20240201160521 ACCESSION NUMBER: 0001104659-24-009452 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240201 FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quipt Home Medical Corp. CENTRAL INDEX KEY: 0001540013 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40413 FILM NUMBER: 24586896 BUSINESS ADDRESS: STREET 1: 1019 TOWN DRIVE CITY: WILDER STATE: KY ZIP: 41076 BUSINESS PHONE: 859-878-2220 MAIL ADDRESS: STREET 1: 1019 TOWN DRIVE CITY: WILDER STATE: KY ZIP: 41076 FORMER COMPANY: FORMER CONFORMED NAME: Protech Home Medical Corp. DATE OF NAME CHANGE: 20200714 FORMER COMPANY: FORMER CONFORMED NAME: Patient Home Monitoring Corp. DATE OF NAME CHANGE: 20120119 6-K 1 tm244946d1_6k.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of January 2024

Commission File Number: 001-40413

Quipt Home Medical Corp.

(Translation of registrant’s name into English)

1019 Town Drive

Wilder, Kentucky 41076

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

EXHIBIT INDEX

Exhibit		Description

99.1		Press Release dated February 1, 2024

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Quipt Home Medical Corp.

Date: February 1, 2024		/s/ Gregory Crawford
		Chief Executive Officer

EX-99.1 2 tm244946d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Quipt Home Medical CORP. to announce FISCAL FIRST Quarter 2024 Financial Results on February 14, 2024

Cincinnati, Ohio – February 1, 2024 – Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal first quarter 2024 financial results on Wednesday, February 14, 2024. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Thursday, February 15, 2024, at 10:00 a.m. (ET).

The call-in numbers for participants are:

Canada/US Toll Free: 1 (800) 319 4610

International: 1 (604) 638 5340

A live webcast of the call will be accessible via the investor section of the Company’s website through the following link: www.quipthomemedical.com.

ABOUT QUIPT HOME MEDICAL

The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.

For further information please visit our website at www.quipthomemedical.com, or contact:

Cole Stevens

VP of Corporate Development

Quipt Home Medical Corp.

859-300-6455

cole.stevens@myquipt.com

Gregory Crawford

Chief Executive Officer

Quipt Home Medical Corp.

859-300-6455

investorinfo@myquipt.com